Please assess the completion status of the following clinical trial:

Trial Title: Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Relapsed or refractory acute myelogenous or lymphoid leukemia.~* Acute myeloid or lymphocytic leukemia in first remission at high-risk for recurrence.~* Chronic myelogenous leukemia in accelerated phase or blast-crisis.~* Chronic myelogenous leukemia in second or subsequent chronic phase~* Recurrent or refractory malignant lymphoma or Hodgkin's disease~* Multiple myeloma at high risk for disease recurrence.~* Chronic lymphocytic leukemia, relapsed or with poor prognostic features.~* Myeloproliferative disorder (polycythemia vera, myelofibrosis) with poor prognostic features.~Exclusion Criteria:~* Clinical progression.~* Contra-indications for vaccination.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Vaccine (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).